Full Access
SUPERFICIAL AND DEEP CANDIDOSIS
ISABELLE THOMAS,
Corresponding Author
ISABELLE THOMAS
M.D.
From the East Orange Veterans Administration Medical Center, East Orange, New Jersey, and the Department of Dermatology, New Jersey Medical School, Newark, New Jersey.
Isabelle Thomas, M.D., 61W 62nd Street, Apt. 7M, New York, NY 10023.Search for more papers by this authorISABELLE THOMAS,
Corresponding Author
ISABELLE THOMAS
M.D.
From the East Orange Veterans Administration Medical Center, East Orange, New Jersey, and the Department of Dermatology, New Jersey Medical School, Newark, New Jersey.
Isabelle Thomas, M.D., 61W 62nd Street, Apt. 7M, New York, NY 10023.Search for more papers by this author
REFERENCES
- 1 Shepherd MG, Poulter RTM, Sullivan PA. Candida albicans: biology, genetics and pathogenicity. Annu Rev Microbiol. 1985; 39: 579–614.
- 2 Odds FC. Candida infections: an overview. Crit Rev Microbiol. 1987; 15: 1–5.
- 3 Ashman RB, Papadimitriou JM. What's new in the mechanisms of host resistance to Candida albicans in fection Pathol Res Pract. 1990; 186: 527–534.
- 4 Van't Wout JW. Clinical manifestations of systemic fungal infections. Mycoses. 1988; 31 (Suppl 2): 9–14.
- 5 Epstein JB. Oral and pharyngeal candidiasis. Postgrad Med. 1989; 85: 257–269.
- 6 Lode H, Hoffken G. Oral candidosis and its role in immunocompromised patients. Mycoses. 1989; 32(Suppl 1): 30–33.
- 7 Ray TL. Oral candidiasis. Dermatol Clin. 1987; 5: 651–662.
- 8 Bosso JA. Fungal infections in pediatric patients. Pharmacotherapy 1990; 10: 150s–153s.
- 9 Gazzard BG, Smith D. Oral candidiasis in HIV-infected patients. Br J Clin Pract. 1990; 71(Suppl): 103–108.
- 10 Merkus JM, Van Heusden AM. Chronic vulvovaginal candidosis: the role of oral treatment. Br J Clin Pract. 1990; 71(Suppl): 81–84.
- 11 Waugh MA. Clinical presentation of candidal balanitis—its differential diagnosis and treatment. Chemo therapy 1982; 28(Suppl 1): 56–60.
- 12 Edwards JE. Candida species. In: GL Mandell, RG Douglas, JE Bennett, eds. Principles and practice of infectious diseases. New York : Churchill Livingstone, 1990: 1943.
- 13 Jorizzo JL. Chronic mucocutaneous candidosis. Arch Dermatol. 1982; 118: 963–965.
- 14 Gosseye S, Nezelof C. T system immuodeficiencies in infancy and childhood. Pathol Res Pract 1978; 171: 142–158.
- 15 Kirkpatrick CH, Windhorst DB. Mucocutaneous candidiasis and thymoma. Am J Med. 1979; 66: 939–945.
- 16 Smego RA, Devoe PW, Sampson HA, et al. Candida meningitis in two children with severe combined immunodeficiency. J Pediatr. 1984; 104: 902–904.
- 17 Sobel JD, Vasquez J. Candidemia and systemic candidiasis. Semin Respir Infect. 1990; 5: 123–137.
- 18 Edwards JE. Invasive Candida infections. N Engl J Med. 1991; 324: 1060–1062.
- 19 Hebert AA, Burton Esterly N. Bacterial and candidal cutaneous infections in the neonate. Dermatol Clin. 1986; 4: 3–21.
- 20 Wingard JR, Merz WG, Saral R. Candida tropicalis: a major pathogen in immunocompromised patients. Ann Intern Med. 1979; 91: 539–543.
- 21 Dally S, Thomas G, Danan M. Candidiasis in heroin abusers. Br Med J. 1983; 287: 1549.
- 22 Leclerc G, Weber M, Contet-Audonneau N, et al. Candida folliculitis in heroin addicts. Int J Dermatol. 1986; 25: 100–102.
- 23 Edwards JE. Candida endophthalmitis. In: GP Bodey, V Fainstein, eds. Candidiasis. New York : Raven Press, 1985: 211.
- 24 Gathe JC, Harris RL, Garland B, et al. Candida osteomyelitis. Report of five cases and review of the liter ature. Am J Med. 1987; 82: 927–937.
- 25 Ray TL. Systemic candidiasis. Dermatol Clin. 1989; 7: 259–268.
- 26 Silverman RA, Rhodes AR, Dennehy PH. Disseminated intravascular coagulation and purpura fulminans in a patient with Candida sepsis. Am J Med. 1986; 80: 679–684.
- 27 Goff JS. Infectious causes of esophagitis. Annu Rev Med. 1988; 39: 163–169.
- 28 Bodey GP, Anaissie EJ. Chronic systemic candidiasis. Eur J Clin Microbiol Infect Dis. 1989; 8: 855–857.
- 29 Lipton SA, Hickey WF, Morris JH, et al. Candidal infection in the central nervous system. Am J Med. 1984; 76: 101–108.
- 30 Buff SJ, McLeiland R, Gallis HA, et al. Candida albicans pneumonia. Radiographic appearance. Am J Roentgenol. 1982; 138: 645–648.
- 31 Odds FC. Candida endocarditis, myocarditis and other cardiovascular Candida infections. In: Candida and candidosis. A review and bibliography. 2nd Ed. London : Bailliere Tindall, 1988: 175.
- 32 Roy JB, Gejer JR, Ohr JA. Urinary tract candidiasis. An update. Urology. 1984; 23: 533–537.
- 33 Lew MA. Diagnosis of systemic Candida infections. Annu Rev Med. 1989; 40: 87–97.
- 34 Walsh TJ, Hathorn JW, Sobel JD, et al. Detection of circulating Candida enolase by immunoassay in patients with cancer and invasive candidiasis. N Engl J Med. 1991; 324: 1026–1031.
- 35 Prentice AG. Oral and gastrointestinal candidosis: prophylaxis during immunosuppressive therapy. Mycoses. 1989; 32(Suppl 2): 42–46.
- 36 Lesher JL, Smith JG. Antifungal agents in dermatology. J Am Acad Dermatol. 1987; 17: 383–394.
- 37 Terrell CL, Hughes CE. Antifungal agents used for deep-seated mycotic infections. Mayo Clin Proc. 1992; 67: 69–91.
- 38 Sobel JD. Individualizing treatment of vaginal candidia sis. J Am Acad Dermatol. 1990; 23: 572–576.
- 39
Komshian SV,
Uwaydah AK,
Sobel JD, et al.
Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient.
Rev Infect Dis.
1989; 2: 379–390.
10.1093/clinids/11.3.379 Google Scholar
- 40 Meunier-Carpentier F, Kiehn TE, Armstrong D. Fungemia in the immunocompromised host. Am J Med. 1981; 71: 363–370.
- 41 Wingard JR, Merz WG, Rinaldi MG, et al. Increase in Candida krusei infection among patients with bone- marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med. 1991; 325: 1274–1277.
Citing Literature
